Diagnostic value of 18 F-FDG PET/CT dual phase imaging in differential diagnosis of benign and malignant pancreatic lesions
Cui Tian,Xiaochen Shu,Zhiguo Wang,Yingying Zhan
DOI: https://doi.org/10.3760/cma.j.issn.1673-8799.2018.01.006
2018-01-01
Abstract:Objective To investigate the diagnostic value of 18 F-FDG PET / CT dual phase ima-ging in differential diagnosis of benign and malignant pancreatic lesions. Methods A retrospective study was performed on 65 cases of patients with pancreatic lesions who underwent PET/CT examination. The fi-nal comprehensive diagnosis was obtained by clinical diagnostic pathology results and clinical long-term clinical follow-up:42 cases of pancreatic malignancy and 23 cases of the benign pancreatic lesions. Prophase scans and delayed scans were administered 50-60 minutes and 120-150 minutes after the intravenous injec-tion of 18 F-FDG,respectively. The SUVmax and RI were calculated for the two time points. The sensitivity, specificity and accuracy were compared. Results The SUVearly of malignant cases was ( 8. 18 ± 3. 52 ) , which was significantly higher than that of benign cases(4. 26 ± 3. 65)(t=7. 94,P<0. 05),the SUVdelay of malignant cases was ( 10. 34 ± 4. 46 ) , which was significantly higher than that of benign cases ( 4. 55 ± 3. 37)(t=2. 67,P<0. 05). There was no significant difference between SUVearly and SUVdelay in benign ca-ses(t=0. 78,P >0. 05),while in malignant cases,SUVdelay was significantly higher than SUVearly (t =-5. 14,P<0. 05). RI of malignant cases was(27. 76 ± 20. 65)％,which was significantly higher than that of benign cases(7. 54 ±17. 33)％(t=8. 42,P<0. 01). The sensitivity,specificity and accuracy of PET/CT in diagnosing pancreatic malignancy were 81. 6％,31. 2％,69. 2％,respectively,while those of dual phase RI were 86. 5％,61. 5％ and 81. 5％. Conclusion 18 F-FDG PET/CT dual phase imaging plays an important role in the diagnosis of benign and malignant pancreatic lesions with higher sensitivity and specificity.